E Fund Management (HK)’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$19.2K Buy
449
+374
+499% +$20.3K 0.01% 324
2026
Q1
$4.71K Hold
75
﹤0.01% 397
2025
Q4
$6.89K Buy
75
+66
+733% +$6.47K ﹤0.01% 223
2025
Q3
$879 Buy
+9
New +$932 ﹤0.01% 215
2025
Q1
Sell
-1,461
Closed -$130K 163
2024
Q4
$130K Buy
1,461
+1,105
+310% +$97.3K 0.1% 42
2024
Q3
$30K Buy
+356
New +$28.1K 0.02% 77

Other funds holding BSX

E Fund Management (HK)'s BSX Position: Q2 2026 in Review

E Fund Management (HK) increased its Boston Scientific (BSX) stake by 499% in Q2 2026, buying an estimated $20.3K and bringing the position to 449 shares worth $19.2K. The position accounts for 0.01% of the portfolio, ranked #324.

E Fund Management (HK) first reported a position in BSX in Q3 2024 and has held it in 6 quarters since. The position peaked at $130K in Q4 2024. 466 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • E Fund Management (HK) held 449 shares of Boston Scientific worth $19.2K as of Q2 2026.
  • E Fund Management (HK) bought 374 Boston Scientific shares in Q2 2026, an estimated $20.3K.
  • Boston Scientific made up 0.01% of E Fund Management (HK)'s portfolio in Q2 2026, its #324 holding.
  • E Fund Management (HK) first reported a position in Boston Scientific in Q3 2024 and has held it in 6 quarters since.
  • E Fund Management (HK)'s Boston Scientific position peaked at $130K in Q4 2024.
  • 466 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on E Fund Management (HK)'s 13F filing for Q2 2026, filed 22 Jul 2026.